Kailera Therapeutics, Inc. Common Stock (KLRA) — Financial Flexibility Index
Kailera Therapeutics, Inc. Common Stock (KLRA) has a Financial Flexibility Index of -0.83x as of June 2026. Free cash flow of $-77.53 Million (operating CF $-77.53 Million minus capex $0.00) represents -1% of total liabilities ($92.95 Million). Check tangible net worth ratio of Kailera Therapeutics, Inc. Common Stock to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kailera Therapeutics, Inc. Common Stock Financial Flexibility Index (2025–2025)
Historical Financial Flexibility Index trend for Kailera Therapeutics, Inc. Common Stock across 1 annual periods. For the full cash flow conversion analysis, see Kailera Therapeutics, Inc. Common Stock operating cash flow efficiency.
Annual Financial Flexibility Index for Kailera Therapeutics, Inc. Common Stock (2025–2025)
Year-by-year free cash flow to debt coverage for Kailera Therapeutics, Inc. Common Stock. Explore debt repayment capacity of Kailera Therapeutics, Inc. Common Stock to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.11x | $-118.12 Million | $-120.21 Million | $1.05 Billion | — |